Drug Type in vivo CAR-T therapy |
Synonyms Arnovie-101 |
Target |
Action inhibitors |
Mechanism CD8 inhibitors(Cluster of differentiation 8 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Haemolytic Anaemias | Clinical | China | 07 Apr 2026 | |
| Autoimmune Haemolytic Anaemias | Clinical | China | 07 Apr 2026 | |
| Systemic Lupus Erythematosus | Clinical | China | 07 Apr 2026 | |
| Systemic Lupus Erythematosus | Clinical | China | 07 Apr 2026 |





